As of 2024-12-15, the Fair Value of Canntab Therapeutics Ltd (PILL.CN) is -0.43 CAD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.01 CAD, the upside of Canntab Therapeutics Ltd is -8,723.75%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2018-05-31 | 2019-05-31 | 2020-05-31 | 2021-05-31 | 2022-05-31 | 5Y Avg | |
| Net income | -2.41 | -2.46 | -2.61 | -4.42 | -3.69 | -3.12 |
| YoY growth | -1,220.04% | -2.08% | -6.05% | -69.52% | 16.53% | -256.23% |
| Market Cap (mil) | 0.19 |
| P/E | |
| Forward P/E |
| EPS | -0.09 |
| Avg earnings growth rate | -256.23% |
| TTM earnings | -3.36 |